4//SEC Filing
Brooke Robert T. 4
Accession 0001144204-11-021814
CIK 0001425205other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 5:21 PM ET
Size
4.6 KB
Accession
0001144204-11-021814
Insider Transaction Report
Form 4
Brooke Robert T.
DirectorPresident, CEO10% Owner
Transactions
- Other
Common Stock
2011-03-25−1,500,000→ 4,440,008 total
Footnotes (1)
- [F1]These shares were cancelled pursuant to the terms of an Advisory Agreement entered into effective February 7, 2011, by the issuer and Mr. Brooke.
Documents
Issuer
Genesis Biopharma, Inc
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001483808
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 5:21 PM ET
- Size
- 4.6 KB